Skip to main content
. 2022 Jul 4;23(9):1590–1602. doi: 10.1016/j.jamda.2022.06.028

Table 3.

Nonpharmacologic Approaches to Mitigate COVID-19 Outbreaks and Mortality in Nursing Homes and Long-Term Care Facilities

Mitigation Measures References Summary
Nursing home infection prevention and control measures
 Mass resident screening 121, 122, 123
  • Rapid systematic review of European, American, and Asian studies, N = 38 studies: Supports use of mass testing in outbreak-affected facilities121

  • Cochrane Review, N = 11 modeling and 11 observational studies: Testing of new admissions and intensified testing of residents and staff after holidays may reduce infections123

  • Cochrane Review, N = 11 modeling and 11 observational studies: Routine testing may reduce infection rates123; however evidence noted as uncertain

 Resident cohorting and physical separation of infected residents 121, 122, 123, 124, 125, 126, 127, 128, 129
  • Rapid systematic review of European, American, and Asian studies, N = 38 studies: supports cohorting protocols to reduce infection rates; however, data limited121

  • Cochrane Review, N = 11 modeling and 11 observational studies: supports use of cohorting to reduce new infections but evidence remains uncertain123

  • USA, N = 360 facilities: decline in weekly infection rates with implementation of infection prevention and control procedures122

  • UK, agent-based modeling study: supports ongoing use of cohorting protocols in outbreak-affected nursing homes129

 Promoting hand and respiratory hygiene 121,122,130
  • USA, N = 2580 residents: Greater implementation of hand and respiratory hygiene associated with lower infection rates130

 Environmental cleaning 123,130
  • USA, N = 2580 residents: Greater implementation of environmental cleaning associated with lower infection rates130

  • Cochrane Review, N = 11 modeling and 11 observational studies: Cleaning and environmental hygiene measures may reduce infection rates but evidence uncertain123

Personal protective equipment
 Supply of personal protective equipment 122,131,132
  • USA, N = 360 facilities: Rapid decline in infection rates following widespread use of personal protective equipment in a large cohort study122

  • Cyprus, N = 5115 facilities: decline in infection rates during intervention period with adoption of personal protective equipment131;

  • USA, stochastic modeling study: Supports continued need for use of personal protective equipment in outbreak-affected facilities despite mass vaccination132

 Training of staff in use of personal protective equipment 133
  • Belgium, N = 617 health care workers: Decreased infections when staff appropriately trained in personal protective equipment use133

Wider societal measures
 Visitation bans 123,129,134,135
  • USA, meta-population modeling study: Reduction in infection rate in areas imposing visitation bans134

  • UK, agent-based modeling study: Reduced infections with visitation bans only when community prevalence where staff live considerably lower than prevalence where visitors live129

  • UK, N = 57,713 individuals: “shielded” individuals had higher rates of infection, after adjustment for nursing home status135

  • Cochrane Review, N = 11 modeling and 11 observational studies: Evidence uncertain to support visitation bans123

Interventions to support outbreak-affected nursing homes
 On site medicalization 136,137
  • Spain, N = 272 residents: On-site medicalization associated with a significantly greater compositive of survival or optimal palliative care136

  • USA, N = 215 residents: partnering with local hospitals successfully implemented, descriptive study137

 Outreach teams 138,139
  • Netherlands, N = 41 long-term care organizations: Outbreak team monitoring successfully implemented, descriptive study138

  • France, N = 63 facilities: Local multidisciplinary mobile team implemented to successfully manage outbreaks139

 Telemedicine 140, 141, 142, 143
  • USA, protocol development to identify telemedicine disruptions and solutions in supporting long-term care facilities: development and validation of several telemedicine platforms through quality improvement cycles142

  • Europe, WONCA statement: expert consensus statement on the development of optimal telemedicine support143